Needle-Free Flu Protection for Children and Adolescents
Needle-Free Flu Protection for Children and Adolescents
In 2026, families in New South Wales will have access to a needle-free influenza (flu) vaccine for young children.
The intranasal FluMist nasal spray vaccine will be free for children aged 2 to under 5 years. It will also be available privately for children and teens up to 18 years of age. FluMist will allow parents to protect their young children from severe flu without the stress of a needle, as it is delivered via a painless and simple nasal spray.
Why is it important to vaccinate my child for the flu?
Although flu can be mild for some, it can also cause serious illness and hospitalisation, even in healthy children. Vaccination helps protect them from severe disease and reduces community spread, helping keep vulnerable people safer.
How does it work?
FluMist is a live-attenuated vaccine, meaning that it contains weakened strains of flu viruses that train the immune system to recognise the viruses. but cannot cause illness in healthy individuals.
It is given as a quick spray into each nostril and is rapidly absorbed. If a child sneezes or blows their nose afterwards, the vaccine will still work and does not need to be repeated.
Common side effects are mild and short-lived, such as a runny nose or other mild respiratory symptoms. The vaccine is not suitable for children who are moderately or severely immunocompromised and should be used with caution for those who are close contacts of people with significant immunocompromise.
Where can my child get the intranasal vaccine?
The intranasal vaccine will be available for free at the GP for children aged two to under five and can be purchased privately for children aged five to under eighteen at GPs and certain pharmacies.
Find out more information about the intranasal flu vaccine in the National Centre for Immunisation Research and Surveillance (NCIRS) Frequently Asked Questions resource.
Immunisation Weekly Update: Welcome to our weekly Immunisation Update! In this week’s update, read about: Transition of COVID-19 vaccines to the NIP Hep B vaccine eligibility No link between vaccines and autism Expansion of the NIP Vaccinations in Pharmacy Program to include children under 5 years National Vaccination Insights project…
HealthPathways is getting a refreshed look From 17 September 2026, HealthPathways Sydney and South Eastern Sydney sites will launch a refreshed layout designed to provide a clearer and more user-friendly experience. New features: Simplified homepage More prominent search bar Improved toolbar for common actions – including CPD notes and expand/collapse…
Immunisation Weekly Update: Welcome to our weekly Immunisation Update! In this week’s update, read about: Protecting Adolescents Against Human Papillomavirus: The Pivotal Role of Primary Care Fluad vaccine stock exhausted COVID-19 vaccine NIP transition Education Protecting Adolescents Against Human Papillomavirus: The Pivotal Role of Primary Care Twenty years after the…
GP Liaison in Alcohol and Other Drugs (GLAD) service support for general practice Evidence shows that people living with significant alcohol or drug related harm often delay seeking care and minimise their healthcare needs. They may live with chronic or complex illnesses with adverse health impacts routinely seen in much older patients. As a result, when assessing…
Immunisation Weekly Update: Diphtheria: NSW Vaccination Recommendations NSW Health childhood vaccination campaign toolkit New respiratory syncytial virus (RSV) maternal vaccination resource Education Diphtheria: NSW Vaccination Recommendations NSW Health is reminding providers to check the diphtheria vaccination status of all Aboriginal people and offer vaccination where eligible. A NSW-funded vaccination program is currently available…
Immunisation Weekly Update: Promote Japanese Encephalitis Vaccination Ahead of Travel Measles Immunity Gaps: A Timely Reminder to Check Vaccine Status COVID-19 vaccination in 2026: preparing for the transition to the National Immunisation Program (NIP) Webinar Education Promote Japanese Encephalitis Vaccination Ahead of Travel Funded JE vaccination is available for eligible…